EP Patent

EP4157262A1 — Pharmaceutical formulations of pilocarpine r-(+)-lipoate

Assigned to Cellix Bio Pvt Ltd · Expires 2023-04-05 · 3y expired

What this patent protects

The present invention relates to a pharmaceutical formulations and compositions comprising cholinergic agonist agents such as pilocarpine-R-(+)-lipoate or its salt, solvate, or hydrate thereof for oral administration with improved compliance, safety, and bioavailability. It f…

USPTO Abstract

The present invention relates to a pharmaceutical formulations and compositions comprising cholinergic agonist agents such as pilocarpine-R-(+)-lipoate or its salt, solvate, or hydrate thereof for oral administration with improved compliance, safety, and bioavailability. It further discloses methods of preparing the formulations and its use for the treatment of xerostomia, dry mouth and Sjogren's syndrome.

Drugs covered by this patent

Patent Metadata

Patent number
EP4157262A1
Jurisdiction
EP
Classification
—
Expires
2023-04-05
Drug substance claim
No
Drug product claim
No
Assignee
Cellix Bio Pvt Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.